Author:
Boyer Alexandre,Timsit Jean-François,Klouche Kada,Canet Emmanuel,Phan Thuy-nga,Bohé Julien,Rubin Sebastien,Orieux Arthur,Lautrette Alexandre,Gruson Didier,Souweine Bertrand
Funder
Ministère des Affaires Sociales et de la Santé
Subject
Pharmacology (medical),Pharmacology
Reference18 articles.
1. Evaluation of "Loss" and "End stage renal disease" after acute kidney injury defined by the Risk, Injury, Failure, Loss and ESRD classification in critically ill patients;Cartin-Ceba;Intensive Care Med,2009
2. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study;Bagshaw;Intensive Care Med,2015
3. Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock;Picard;Antimicrob Agents Chemother,2014
4. Back to the future: using aminoglycosides again and how to dose them optimally;Drusano;Clin Infect Dis,2007
5. Recommended dose of arbekacin, an aminoglycoside against methicillin-resistant Staphylococcus aureus, does not achieve desired serum concentration in critically ill patients with lowered creatinine clearance;Fukuoka;J Clin Pharm Ther,2008
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献